Related Experiment Videos
[Ceftriaxone vs. cefazolin in obstetrical surgical prevention]
R Figueroa Damián1, F J Ortíz Ibarra, V M Labastida Domínguez
1Departamento de Infectología e Immunología, Instituto Nacional de Perinatología, México, D.F.
Ginecologia Y Obstetricia De Mexico
|July 1, 1995
Summary
Single-dose ceftriaxone is a safe and effective antibiotic prophylaxis for preventing puerperal infections in cesarean section patients with infection risk factors. This approach simplifies administration and reduces adverse reactions compared to multi-dose cefazolin.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Cesarean sections carry a high risk of puerperal infections.
- Antibiotic prophylaxis can reduce infectious complications in obstetric surgery.
- Prophylaxis is most effective in patients with identified infection risk factors.
Purpose of the Study:
- To compare the prophylactic efficacy of single-dose ceftriaxone versus three-dose cefazolin in preventing puerperal infections.
- To evaluate the safety and ease of administration of different antibiotic prophylaxis regimens.
Main Methods:
- A comparative study involving 100 patients undergoing cesarean section with risk factors for infection.
- Patients were randomized into two groups: 50 received single-dose ceftriaxone, and 50 received three-dose cefazolin.
- Puerperal infection incidence was monitored in both groups.
Main Results:
- Puerperal infections occurred in 6% of the ceftriaxone group and 12% of the cefazolin group.
- Statistical analysis did not reveal a significant difference in infection rates between the two groups.
- Single-dose ceftriaxone demonstrated comparable efficacy to multi-dose cefazolin.
Conclusions:
- Single-dose ceftriaxone is a viable and effective option for antibiotic prophylaxis in high-risk cesarean section patients.
- The single-dose regimen offers advantages in ease of application and safety, potentially reducing adverse reactions.
- This approach simplifies the prophylactic strategy while maintaining comparable clinical outcomes.